Tag: EAACI

ALK Abello Four leading experts in respiratory allergy spotlight the impact of respiratory allergy in children, in an ALK-sponsored symposium at the EAACI Congress The growing availability of evidence-based allergy immunotherapy treatments for paediatric patients offers increased treatment options for prescribers ALK has enrolled more than 3,000 paediatric patients in eight Phase III clinical trials […]